| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/16/2014 | CN102634531B Medicine T-VISA-PEA15 capable of effectively and specifically killing breast cancer cells |
| 04/16/2014 | CN102617698B Method for preparing fine dioscin and application of fine dioscin |
| 04/16/2014 | CN102617599B Macrocyclic compound and application thereof |
| 04/16/2014 | CN102603555B All-trans retinoic acid amide derivative and preparation method and application thereof |
| 04/16/2014 | CN102600298B Traditional Chinese medicine for treating lung cancer and application of the medicine |
| 04/16/2014 | CN102574836B Aminopyrazole derivative |
| 04/16/2014 | CN102574835B Compounds useful for treating cancer |
| 04/16/2014 | CN102548987B Fluoro-substituted compounds as kinase inhibitors and methods of use thereof |
| 04/16/2014 | CN102532236B Steroid 5Alpha-reductase inhibitors, preparation methods thereof and medical applications thereof |
| 04/16/2014 | CN102491931B 3-substituted indolone derivative and preparation method and application thereof |
| 04/16/2014 | CN102481278B Composition for alleviating ultraviolet radiation-induced damage |
| 04/16/2014 | CN102477039B Method for preparing Fissistigma oldhamii lactam alkali compound and application thereof to preparing anti-tumour medicine |
| 04/16/2014 | CN102443009B Fused ring kinase inhibitor |
| 04/16/2014 | CN102408380B 5-aminopyrimidine-thione compounds and preparation method thereof |
| 04/16/2014 | CN102399870B Reagent for determining survival and prognosis of patients with esophagus cancer |
| 04/16/2014 | CN102399258B Androstane [17,16-d] [1,2,4] triazole [1,5-a] pyrimidine derivatives and synthesis and application thereof |
| 04/16/2014 | CN102372630B Resorcinol derivative with antitumor activity, its preparation method and application |
| 04/16/2014 | CN102370695B Qinglongyi active extract, its preparation method and its application |
| 04/16/2014 | CN102369195B Autotaxin inhibitors |
| 04/16/2014 | CN102357202B Traditional Chinese medicine cancer toxin prescription for treating liver cancer and application thereof in pharmacy |
| 04/16/2014 | CN102335258B Medicine for resisting tumour, and preparation methods and application thereof |
| 04/16/2014 | CN102311395B Quinazoline ring substituted diphenylurea derivative and its purpose |
| 04/16/2014 | CN102264725B 蛋白激酶抑制剂 Protein kinase inhibitors |
| 04/16/2014 | CN102249940B Amphiphilic benzylidene cyclopentanone dye, its synthetic method and application in two-photon photodynamic therapy |
| 04/16/2014 | CN102245597B Compounds useful for inhibiting CHK1 |
| 04/16/2014 | CN102245560B Ethoxy diphenyl ethane derivates, preparation processes and uses thereof |
| 04/16/2014 | CN102066378B 3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazine derivatives as MET kinase inhibitors |
| 04/16/2014 | CN101993388B Dimerization cassaine alkaloids as well as preparation method, pharmaceutical compositions and applications of dimerization cassaine alkaloids |
| 04/16/2014 | CN101970496B Antibody against the csf-1 r |
| 04/16/2014 | CN101970425B Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts |
| 04/16/2014 | CN101952426B Anti-BST2 antibody |
| 04/16/2014 | CN101891792B Triterpene compounds in salvia miltiorrhiza flower and extraction method and application thereof |
| 04/16/2014 | CN101822657B Pachysandra terminalis alkaloid compound for resisting tumor metastasis |
| 04/16/2014 | CN101687039B Engineered anti-alpha v- integrin hybrid antibodies |
| 04/16/2014 | CN101591332B Compound based on 4-phenyl-6-(2, 2, 2-trifluoro-1-phenylethoxy) pyridine and application method thereof |
| 04/15/2014 | US8697866 Substituted pyridazine carboxamide compounds as kinase inhibitor compounds |
| 04/15/2014 | US8697836 Composition and method for inducing and enhancing a telomerase reverse transcriptase-reactive cytotoxic T lymphocyte response |
| 04/15/2014 | US8697743 Antioxidant camptothecin derivatives and antioxidant antineoplastic nanospheres thereof |
| 04/15/2014 | US8697717 Inhibitors of histone deacetylase |
| 04/15/2014 | US8697698 Pyrazole compounds useful as protein kinase inhibitors |
| 04/15/2014 | US8697348 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571 |
| 04/15/2014 | US8697137 Methods of using microspheres for active embolization |
| 04/15/2014 | US8697104 Apparatus, system, and method for creating immunologically enhanced spaces in-vivo |
| 04/15/2014 | US8697098 Polymer conjugated protein micelles |
| 04/15/2014 | US8697077 Methods and compositions for treating autoimmune diseases |
| 04/15/2014 | US8697069 Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cells |
| 04/15/2014 | US8697061 Tumor specific oligosaccharide epitopes and use thereof |
| 04/15/2014 | CA2712005C Pharmaceutical solid state forms |
| 04/15/2014 | CA2660376C Salts of benzimidazolyl pyridyl ethers and formulations thereof |
| 04/15/2014 | CA2578267C Methods for making retinoids and uses thereof |
| 04/15/2014 | CA2565215C Method and system to remove soluble tnfr1, tnfr2, and il2 in patients |
| 04/15/2014 | CA2427643C Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc) |
| 04/15/2014 | CA2383877C Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
| 04/15/2014 | CA2328414C Methods for detecting and inhibiting angiogenesis |
| 04/10/2014 | WO2014055998A1 Human anti-vegfr-2/kdr antibodies |
| 04/10/2014 | WO2014055938A1 Novel compounds, their preparation and their uses |
| 04/10/2014 | WO2014055913A1 Treatment of cancer |
| 04/10/2014 | WO2014055842A1 Process for preparing stable antibody maytansinoid conjugates |
| 04/10/2014 | WO2014055835A1 Alternative pathway specific antibodies for treating hemolytic diseases |
| 04/10/2014 | WO2014055682A1 Immunomodulatory minicells and methods of use |
| 04/10/2014 | WO2014055657A1 Use of a trans-signaling approach in chimeric antigen receptors |
| 04/10/2014 | WO2014055648A1 Combination of anti-kir antibodies and anti-pd-1 antibodies to treat cancer |
| 04/10/2014 | WO2014055624A1 Methods relating to dna-sensing pathway related conditions |
| 04/10/2014 | WO2014055415A1 Cancer treatments |
| 04/10/2014 | WO2014055039A1 Peptides and methods for treating cancer |
| 04/10/2014 | WO2014054884A1 Composition for hyperthermia comprising sensitization material |
| 04/10/2014 | WO2014054798A1 Drug for inhibiting malignant tumor metastasis |
| 04/10/2014 | WO2014054004A1 Preeclamptic placental mesenchymal stem cell conditioned medium for use in the treatment of a tumour |
| 04/10/2014 | WO2014053999A1 Cxcl3 chemokine for the therapeutic treatment of medulloblastoma |
| 04/10/2014 | WO2014053968A1 Pyrrolo[3,2-c]pyridine tropomyosin-related kinase inhibitors |
| 04/10/2014 | WO2014053967A1 Pyrrolo[2,3-d]pyrimidine tropomyosin-related kinase inhibitors |
| 04/10/2014 | WO2014053965A1 Tropomyosin-related kinase inhibitors |
| 04/10/2014 | WO2014053851A1 Treatment of cancer |
| 04/10/2014 | WO2014053650A1 Use of masitinib for treatment of cancer in patient subpopulations identified using predictor factors |
| 04/10/2014 | WO2014053568A1 Indolyldihydroimidazopyrimidinone derivatives, preparation thereof and therapeutic use thereof |
| 04/10/2014 | WO2014053491A1 Inhibitors of histone demethylases |
| 04/10/2014 | WO2014053208A1 7-azaindol-2,7-naphthyridine derivative for the treatment of tumors |
| 04/10/2014 | WO2014053014A1 Modulation of rna activity and vascular permeability |
| 04/10/2014 | WO2014023390A3 (aza-)isoquinolinone derivatives |
| 04/10/2014 | WO2013184912A3 Binding agents that modulate the hippo pathway and uses thereof |
| 04/10/2014 | WO2013054331A8 Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam) |
| 04/10/2014 | WO2012142313A8 Micro-rna inhibitors and their uses in disease |
| 04/10/2014 | US20140100261 Trpm-2 antisense therapy |
| 04/10/2014 | US20140100174 Treatment for Cancer |
| 04/10/2014 | US20140100163 Non-peptide agonists and antagonists of adrenomedullin and gastrin releasing peptide |
| 04/10/2014 | US20140099307 New Dendritic Cell Co-Stimulatory Molecules |
| 04/10/2014 | US20140099305 Compositions and methods for cancer immunotherapy |
| 04/10/2014 | US20140099279 Metal alloys for medical devices |
| 04/10/2014 | US20140099255 Polymer based radionuclide containing particulate material |
| 04/09/2014 | EP2716764A1 Construction and application of mutant type b human adenovirus ad11 having enhanced oncolytic power |
| 04/09/2014 | EP2716756A1 Reic-expressing adenovirus vector |
| 04/09/2014 | EP2716653A1 Truncated human papillomavirus type 33 protein l1 |
| 04/09/2014 | EP2716652A1 Anti-fatty acid synthase polypeptide and use thereof |
| 04/09/2014 | EP2716643A1 Pyrrolopyrimidine compounds and their uses |
| 04/09/2014 | EP2716633A1 Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof |
| 04/09/2014 | EP2716626A1 Benzylamine derivative |
| 04/09/2014 | EP2716301A2 Antibodies against ERBB3 and uses thereof |
| 04/09/2014 | EP2716297A1 Activity enhancer for anticancer agent |
| 04/09/2014 | EP2716293A1 Anti-tumor agent |
| 04/09/2014 | EP2716292A1 Cdc42 inhibitor and uses thereof |